Published by Abigail Townsend on 21st September 2020
(Sharecast News) - US healthcare firm Illumina is to take full control of blood test specialist Grail in a $8bn cash and stock deal, it was announced on Monday.
URL: http://www.digitallook.com/dl/news/story/31201657/...